As RFK Jr. winds down mRNA vaccine research, experts warn America may lose its edge in vaccine development, putting public health at risk and ceding ground to adversaries like China.
The US government has made a controversial move by terminating $500 million in grants for mRNA vaccine research, a technology that saved millions during COVID-19. Experts warn this could hinder future health advancements.
In a surprising move, the US Department of Health has canceled contracts worth $500 million related to mRNA vaccine research, sparking concerns about future pandemic preparedness and the direction of vaccine technology.
HHS Secretary Robert F. Kennedy Jr. has sparked outrage by canceling $500 million in mRNA vaccine research grants, citing questionable data. Experts warn this could hinder public health efforts and the future of vaccine technology.
Health Secretary Robert F. Kennedy Jr.'s drastic funding cuts to mRNA vaccine research could stymie medical breakthroughs and push scientific talent away from the U.S., experts warn.
Former Surgeon General Dr. Jerome Adams warns that the U.S. risks lives by cutting funding for mRNA vaccine research, following Secretary Kennedy's controversial decision to halt key projects.
In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.
The Trump administration's sudden cancellation of a $258 million HIV vaccine research program has ignited outrage among scientists and public health advocates, jeopardizing years of progress in HIV prevention and treatment as infection rates surge.
In a shocking move, the Department of Health has appointed vaccine skeptic David Geier to lead a new NIH study. Experts warn this could undermine decades of scientific research on vaccines and public health.
In a controversial move, NIH officials may be pushing to eliminate mRNA vaccine technology from grant applications, signaling a potential halt in vital medical research. Scientists express fears over job security and funding.
